The Drug-Induced Respiratory Disease Website and App

Frequency - Incidence

Incidence of respiratory adverse event(s) due to the specific drug as assessed by number of reported/published cases in the literature. Red digits in stars indicate: 0 = Very rare, questionable signal · 1 = < 10 cases · 2 = 10-50 cases · 3 = 50–100 cases · 4 = 100-200 cases · 5 = >200 cases

Evidence level/grade

Evidence level for respiratory adverse event(s) due to the specific drug as estimated using Hill’s (1965), Naranjo’s (1981), and Bégaud’s (1985) criteria applied to published cases. Blue digits in stars indicate: 0 = Questionable · 1 = Low · 2 = Moderate · 3 = Robust · 4 = Definite · 5 = Unquestionable, pathognomonic

XI.b

Chest pain (acute or subacute), lone or prominent

Publications

Hearn JW, Videtic GM, Djemil T, Stephans KL

Salvage stereotactic body radiation therapy (SBRT) for local failure after primary lung SBRT.

International journal of radiation oncology, biology, physics 2014 Oct 01;90;402-6 — 2014 Oct 01 — 402-6

Coroller TP, Mak RH, Lewis JH, Baldini EH, Chen AB, Colson YL, Hacker FL, Hermann G, Kozono D, Mannarino E, Molodowitch C, Wee JO, Sher DJ, Killoran JH

Low incidence of chest wall pain with a risk-adapted lung stereotactic body radiation therapy approach using three or five fractions based on chest wall dosimetry.

PloS one 2014;9;e94859 — 2014 — e94859

Videtic GM, Stephans K, Reddy C, Gajdos S, Kolar M, Clouser E, Djemil T

Intensity-modulated radiotherapy-based stereotactic body radiotherapy for medically inoperable early-stage lung cancer: excellent local control.

International journal of radiation oncology, biology, physics 2010 Jun 01;77;344-9 — 2010 Jun 01 — 344-9